Sheba Medical Center signed an agreement with OpenAI reported at 04:09 UTC on 28 July, becoming the first hospital outside the United States to get access to the company's healthcare model suite. The deal was signed with Nate Gross, OpenAI's head of health.

What the agreement covers

Access to ChatGPT Health, introduced in January 2026, plus OpenAI's dedicated medical models — ahead of the broad US rollout. Sheba's clinical teams join product development, and the hospital's clinical protocols are to be integrated into the systems. A Sheba delegation visits OpenAI's headquarters in August.

The shape of the deal

This is worth reading carefully, because "hospital adopts OpenAI" is not what happened. There is no disclosed contract value, no patient volume, no named department and no outcome data. What is described is early access plus co-development — OpenAI gets a large clinical partner to develop against, and Sheba gets the models first. That is a research relationship with a commercial option attached, not a deployment. Sheba's own "world's first AI-powered hospital" framing is its marketing, not a measured claim.

The regulatory position

These models are not FDA-regulated medical devices. A general-purpose model answering clinical questions occupies a gap in medical device regulation that regulators on both sides of the Atlantic have not closed — which is part of why co-development inside a hospital, rather than a cleared product sold to one, is the workable structure right now.

Why Israel

Sheba runs one of the larger digital health innovation operations in the world and has a long history as a test site for medical technology, with a national health system whose records are unusually well digitised and centralised. For a company that needs clinical feedback loops faster than the American regulatory and procurement cycle allows, that combination is the point. It is also, notably, a jurisdiction where OpenAI can iterate without a US liability record accumulating.

Sourcing note

The report rests on two Israeli outlets; neither OpenAI nor Sheba has published a newsroom statement, which is a thinner evidentiary base than a hospital partnership of this profile would normally carry.